Stocks and Investing Stocks and Investing
Mon, January 9, 2023
Sun, January 8, 2023

Jonathan Wolleben Maintained (SPRB) at Buy and Held Target at $8 on, Jan 8th, 2023


Published on 2024-10-28 00:48:17 - WOPRAI, Jonathan Wolleben
  Print publication without navigation


Jonathan Wolleben of JMP Securities, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $8 on, Jan 8th, 2023.

Jonathan has made no other calls on SPRB in the last 4 months.



There is 1 other peer that has a rating on SPRB. Out of the 1 peers that are also analyzing SPRB, 0 agree with Jonathan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jonathan


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $8 on, Thursday, November 17th, 2022
Contributing Sources